Search

everythinglearnresearchcommunity

for

Search:↓

Deuruxolitinib effectively treats alopecia areata but may cause manageable side effects.

Higher Lnk protein levels in ovaries may lead to insulin resistance in women with PCOS.

Type B Insulin Resistance Syndrome is rare, linked to lupus, and hard to treat due to severe insulin resistance.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.

An over-the-counter vitamin/mineral supplement improved hair loss and blood sugar control in a woman with non-classic 11-hydroxylase deficiency.

Altered lipid pathways in diabetic women may cause premature greying.

Dietary essential fatty acids improved skin and hair conditions and partially corrected fat composition in diabetic mice.

Nilotinib can cause keratosis pilaris, a skin condition.

Deuruxolitinib improves hair regrowth in alopecia areata but needs more safety research.

Teriflunomide is effective and generally safe for treating relapsing multiple sclerosis, reducing relapse rates and disability progression.

Ivarmacitinib effectively regrows hair in severe alopecia areata.

Metformin helps manage weight, blood pressure, and hormonal imbalances in PCOS patients.

Janus kinase inhibitors may help treat lichen planopilaris.

A newborn with severe low blood sugar due to a genetic issue needed major surgery after standard treatments failed.

Intralesional triamcinolone acetonide can effectively limit the progression of GLPLS.

Semaglutide may worsen eating disorders in vulnerable individuals.

Blocking the enzyme 11β-HSD1 might help treat obesity and metabolic issues.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

Aldesleukin can treat certain cancers and increase HIV patient CD4+ counts but often causes severe side effects.

A new metformin-based treatment may effectively promote hair growth with fewer side effects.

Kanglaite injection with chemotherapy improves treatment and reduces side effects for advanced lung cancer.

The treatment combination is effective and generally safe for lung cancer.

Tofacitinib significantly improved skin and hair conditions without side effects.

Combining Ficlatuzumab and Gefitinib can cause severe hair loss.

Sinapic acid may help fight obesity and promote hair growth.

Latanoprostene bunod effectively lowers eye pressure and is better tolerated than other glaucoma medications.